| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |